Clobazam

Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics
Yu-Tze Ng, Stephen D Collins

Abstract

Catastrophic childhood epilepsies such as infantile spasms (IS), progressive myoclonic epilepsy, and Lennox-Gastaut syndrome (LGS) are rare but debilitating and frequently persist into adulthood. Early, targeted use of medications that have demonstrated efficacy in the management of LGS or its associated epilepsies may simplify the patient's treatment regimen and reduce the incidence of adverse events. Key to the overall benefit to the patient is to maximize seizure control while minimizing adverse effects, especially behavioral and cognitive problems. Clobazam has demonstrated clinical benefit and has been administered safely in more than 50 European studies in which data were reported on greater than 3000 pediatric and adult patients with epilepsy, 300 of whom were diagnosed with LGS; therefore, its use is now being investigated in the U.S. This review will explore the use of clobazam in the treatment of epilepsy, particularly with regard to its potential benefit in LGS. Though not currently approved for use in the U.S., a program is underway to gain Food and Drug Administration approval for the treatment of pediatric and adult patients with refractory epilepsy, specifically in LGS. A phase 2 study will be completed in late 2...Continue Reading

References

Jan 1, 1979·British Journal of Clinical Pharmacology·D R DoongajiS S Thatte
Jan 1, 1979·British Journal of Clinical Pharmacology·W RuppO Vanderbeke
Apr 1, 1976·Toxicology and Applied Pharmacology·R GlomotB Vannier
Aug 1, 1990·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A H GubermanA L Sherwin
Aug 1, 1990·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·D L KeeneP Humphreys
Mar 1, 1989·Neurophysiologie clinique = Clinical neurophysiology·A D Kazis
Aug 1, 1986·Archives of Neurology·D SchmidtU Roeder-Wanner
Dec 1, 1987·Australian and New Zealand Journal of Medicine·C J KilpatrickR F Moulds
Jul 1, 1988·Epilepsy Research·A J HellerE H Reynolds
Jan 1, 1988·Epilepsia·N Callaghan, T Goggin
Jun 1, 1988·Acta Neurologica Scandinavica·D F Scott, A Moffett
Feb 1, 1987·British Journal of Clinical Pharmacology·J R HaighM Feely
Nov 1, 1985·Neurology·Peter R CamfieldB Garner
Oct 1, 1972·Bulletin of Environmental Contamination and Toxicology·V LewinF H Wolfe
Jan 1, 1972·The Journal of Clinical Investigation·C V DeShazoC G Cochrane
Mar 1, 1972·Toxicology and Applied Pharmacology·E W Schafer
Oct 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·M FranceschiS Smirne
Dec 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·M Feely, J Gibson
Apr 16, 1983·British Medical Journal·J W AllenS S Jawad
Jan 1, 1983·European Journal of Clinical Pharmacology·H G GrigoleitP U Witte
Dec 1, 1983·British Journal of Clinical Pharmacology·B CenraudP Loiseau
Jan 1, 1982·Brain & Development·H ShimizuH Yabuuchi
Jan 1, 1982·Journal of Clinical Pharmacology·M DivollR I Shader
Jul 1, 1982·Italian Journal of Neurological Sciences·M PapiniA Pasquinelli
Jun 1, 1981·British Journal of Clinical Pharmacology·G TedeschiA Baruzzi
Nov 1, 1993·Pediatric Neurology·R Munn, K Farrell
Apr 1, 1997·Journal of Child Neurology·J G TheisP Hwang
Oct 13, 2000·Regulatory Toxicology and Pharmacology : RTP·J HellwigC Gembardt
Sep 4, 2001·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·H Nakajima
Mar 29, 2002·Journal of Child Neurology·Patricia K Crumrine
Nov 20, 2002·Pharmacogenomics·Barry Deutsch
Nov 27, 2002·Therapeutic Drug Monitoring·Manuela ContinA Baruzzi
May 24, 2003·Seizure : the Journal of the British Epilepsy Association·M M MehndirattaGurubax Singh
Jun 18, 2003·Seizure : the Journal of the British Epilepsy Association·Hisako ShimizuKousuke Kanemoto
Oct 29, 2003·Toxicology Letters·Izuru MiyawakiNobuo Matsuoka
Dec 4, 2003·British Journal of Clinical Pharmacology·N CazaliGérard Pons
Jan 22, 2004·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·Omkar N Markand
May 26, 2004·Biochemical Society Transactions·K A WaffordT W Rosahl
May 24, 2005·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·M G EvandriG Mazzanti
Mar 1, 2012·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Keijiro MizukamiOsamu Yamato

Citations

Oct 5, 2012·CNS Drugs·Lily P H Yang, Lesley J Scott
Dec 4, 2008·Clinical Neuropharmacology·Maria A MontenegroLawrence J Hirsch
Jan 28, 2009·Epilepsia·Joan ConryJulie Stolle
Apr 2, 2009·Neuropsychiatric Disease and Treatment·Kenou van Rijckevorsel
May 10, 2008·Pharmacogenomics·Takayuki SeoKazuko Nakagawa
Mar 28, 2012·Expert Review of Neurotherapeutics·Hussam Seif-Eddeine, Yu-Tze Ng
Feb 13, 2016·Epilepsy & Behavior Case Reports·Angela C GauthierRichard H Mattson
Aug 14, 2012·Pediatric Neurology·Amanda F VanStraten, Yu-Tze Ng
Dec 25, 2010·Seminars in Pediatric Neurology·Catherine J Chu-Shore, Elizabeth A Thiele
Nov 26, 2010·Pediatric Neurology·Nobusuke KimuraMasatoshi Ito
Aug 12, 2010·Thérapie·Danièle Bentué-FerrerSuivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique
Mar 18, 2016·Current Neurology and Neuroscience Reports·Derek J Chong, Andrew M Lerman
Apr 29, 2015·CNS Neuroscience & Therapeutics·Angela C Gauthier, Richard H Mattson
May 13, 2015·Epilepsia·Sanjeev SivakumarWazim Mohamed
Jan 17, 2012·Expert Opinion on Pharmacotherapy·Melissa GiarratanoSelim R Benbadis
Nov 16, 2010·Seizure : the Journal of the British Epilepsy Association·Martin J Brodie
Oct 8, 2013·Epilepsy & Behavior : E&B·David D MottJanet L Fisher
Jan 18, 2011·European Journal of Pharmacology·Janet L Fisher
Oct 18, 2014·European Journal of Clinical Pharmacology·Sachiyo HashiKazuo Matsubara
Jun 3, 2016·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Leslie A RudzinskiIoannis Karakis
Nov 1, 2012·Journal of Child Neurology·M Scott PerryAngel Hernandez
Nov 1, 2012·Journal of Child Neurology·James W Wheless, Stephanie J Phelps
May 3, 2014·Therapeutic Advances in Neurological Disorders·Gabriela Purcarin, Yu-Tze Ng
Oct 5, 2018·Journal of Clinical Pharmacology·Dwain Tolbert, Frank Larsen
Aug 3, 2019·Expert Opinion on Pharmacotherapy·Frank M C Besag, Michael J Vasey
Jan 31, 2019·Clinical Toxicology : the Official Journal of the American Academy of Clinical Toxicology and European Association of Poisons Centres and Clinical Toxicologists·David BoelsVincent Souday
May 11, 2018·Therapeutic Drug Monitoring·Gabrielle R RussellJames W Wheless
Oct 26, 2018·Epilepsia·Allen H HellerA Mark Schobel
Jan 16, 2020·Paediatric Drugs·Gregory L Holmes
Aug 18, 2017·The New England Journal of Medicine·Rongrui Tang, Fang Fang
Jan 12, 2016·Therapeutic Drug Monitoring·Margrete L BurnsCecilie Johannessen Landmark
Dec 11, 2020·Expert Review of Neurotherapeutics·Giovanni MastroianniEdoardo Ferlazzo
Nov 7, 2020·Seminars in Neurology·Rana Moosavi, Christa B Swisher

Related Concepts

Urbanyl
Anticonvulsants
Benzodiazepines
Brain
Clinical Trials
Single Seizure

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.